Published in J Infect Dis on March 01, 2008
Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev (2010) 3.58
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis (2012) 2.74
Meningococcal carriage and disease--population biology and evolution. Vaccine (2009) 2.62
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun (2008) 2.29
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol (2010) 2.11
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol (2009) 2.11
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
Review of meningococcal group B vaccines. Clin Infect Dis (2010) 1.58
Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines (2009) 1.54
Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology (2009) 1.54
Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods. J Clin Microbiol (2012) 1.50
Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol (2012) 1.48
The changing epidemiology of meningococcal disease in North America 1945-2010. Hum Vaccin Immunother (2012) 1.45
Retracted Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines. PLoS One (2015) 1.39
Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One (2011) 1.35
Population genomics: diversity and virulence in the Neisseria. Curr Opin Microbiol (2008) 1.34
Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis (2010) 1.31
Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis (2012) 1.26
Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clin Vaccine Immunol (2012) 1.25
Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol (2012) 1.20
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis (2011) 1.19
Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era. Clin Vaccine Immunol (2008) 1.19
Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol (2011) 1.18
Vaccines for gonorrhea: can we rise to the challenge? Front Microbiol (2011) 1.16
Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine (2009) 1.08
Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence. Hum Vaccin Immunother (2013) 1.04
Meningococcal glycoconjugate vaccines. Hum Vaccin (2011) 1.01
Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. J Clin Microbiol (2014) 1.00
The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis? Philos Trans R Soc Lond B Biol Sci (2013) 0.99
Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. PLoS Pathog (2012) 0.97
Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine. Hum Vaccin Immunother (2013) 0.95
Nontypeable pneumococcal isolates among navajo and white mountain apache communities: are these really a cause of invasive disease? J Infect Dis (2012) 0.95
Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction. Clin Vaccine Immunol (2012) 0.95
The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape. Epidemiol Infect (2012) 0.94
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac. BMC Infect Dis (2014) 0.92
Global practices of meningococcal vaccine use and impact on invasive disease. Pathog Glob Health (2014) 0.91
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci U S A (2013) 0.91
Evolutionary and genomic insights into meningococcal biology. Future Microbiol (2012) 0.90
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands. BMC Infect Dis (2012) 0.90
Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother (2013) 0.89
Meningococcal conjugate vaccines: optimizing global impact. Infect Drug Resist (2011) 0.89
Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience. Adv Prev Med (2011) 0.88
Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci. Infect Immun (2011) 0.88
Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009. Clin Vaccine Immunol (2011) 0.88
The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. PLoS One (2010) 0.88
Vaccine development against Neisseria meningitidis. Microb Biotechnol (2011) 0.87
Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study. BMC Infect Dis (2013) 0.87
Carriage of meningococci by university students, United Kingdom. Emerg Infect Dis (2011) 0.86
Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010. Emerg Infect Dis (2014) 0.85
Biofilm formation by the human pathogen Neisseria meningitidis. Med Microbiol Immunol (2010) 0.85
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One (2013) 0.84
Opa protein repertoires of disease-causing and carried meningococci. J Clin Microbiol (2008) 0.84
Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands. PLoS One (2013) 0.84
Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgG. PLoS One (2011) 0.83
Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba. J Clin Microbiol (2009) 0.83
Vaccines for the unvaccinated: protecting the herd. J Infect Dis (2008) 0.83
A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years. Hum Vaccin Immunother (2012) 0.83
Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood. Clin Vaccine Immunol (2011) 0.83
Commencement of the meningococcal vaccination for the republic of Korea army. Infect Chemother (2013) 0.82
Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine. Clin Vaccine Immunol (2010) 0.82
The 2011 Garrod Lecture: From penicillin-binding proteins to molecular epidemiology. J Antimicrob Chemother (2012) 0.82
The Evolution of the Meningitis Vaccine Project. Clin Infect Dis (2015) 0.82
Meningococcal Vaccinations. Infect Dis Ther (2016) 0.82
Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers. PLoS One (2014) 0.81
Can we, should we, eradicate the meningococcus? Vaccine (2012) 0.81
Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics. Trans Am Clin Climatol Assoc (2011) 0.81
Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008). PLoS One (2009) 0.81
Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease. Infect Drug Resist (2011) 0.80
From genes to vaccine: A breakthrough in the prevention of meningococcal group B disease. Paediatr Child Health (2011) 0.80
Structural and kinetic characterizations of the polysialic acid O-acetyltransferase OatWY from Neisseria meningitidis. J Biol Chem (2009) 0.80
Editorial commentary: fifteen years of protection by meningococcal C conjugate vaccines: lessons from disease surveillance. Clin Infect Dis (2014) 0.80
A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice. Vaccine (2015) 0.79
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country. Hum Vaccin Immunother (2015) 0.79
Clinical and laboratory evidence for Neisseria meningitidis biofilms. Future Microbiol (2009) 0.79
Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century. Hum Vaccin Immunother (2012) 0.78
Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines. PLoS One (2015) 0.78
Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study. Eur J Pediatr (2013) 0.78
The Long Road to an Effective Vaccine for Meningococcus Group B (MenB). Ann Med Surg (Lond) (2013) 0.78
Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults. Clin Vaccine Immunol (2011) 0.78
The endgame for serogroup a meningococcal disease in Africa? Clin Infect Dis (2012) 0.78
Meningococcal B vaccination strategies and their practical application in Italy. J Prev Med Hyg (2015) 0.78
Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years. Clin Vaccine Immunol (2013) 0.77
Pharyngeal carriage of Neisseria species in the African meningitis belt. J Infect (2016) 0.77
Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994-2012 series. Hum Vaccin Immunother (2016) 0.76
Effectiveness of meningococcal C conjugate vaccine in salvador, Brazil: a case-control study. PLoS One (2015) 0.76
Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation. Vaccine (2016) 0.76
Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis. PLoS One (2014) 0.76
Genomic Analysis of Serogroup Y Neisseria meningitidis Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms. J Infect Dis (2016) 0.75
Impact of vaccination on meningococcal epidemiology. Hum Vaccin Immunother (2015) 0.75
Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa. Pathog Glob Health (2017) 0.75
Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. Expert Rev Vaccines (2016) 0.75
High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med (2017) 0.75
A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures? BMC Infect Dis (2014) 0.75
Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines. BMC Med (2016) 0.75
Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response. Clin Vaccine Immunol (2012) 0.75
Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement. Hum Vaccin Immunother (2016) 0.75
Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015). PLoS One (2016) 0.75
Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013. Mem Inst Oswaldo Cruz (2017) 0.75
Recent progress in the prevention of serogroup B meningococcal disease. Clin Vaccine Immunol (2017) 0.75
Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage. J Prev Med Hyg (2015) 0.75
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis (2010) 7.60
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis (2012) 7.18
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis (2003) 5.73
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis (2011) 5.31
Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res (2010) 5.29
Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet (2002) 5.11
Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol (2003) 4.47
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr (2010) 4.12
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open (2012) 3.93
Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev (2008) 3.80
Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut (2011) 3.71
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis (2012) 3.71
Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog (2007) 3.65
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ (2012) 3.44
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ (2008) 3.32
Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis (2004) 3.31
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet (2002) 3.30
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29
No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. Lancet Infect Dis (2006) 3.18
A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. Emerg Infect Dis (2002) 3.18
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis (2013) 3.15
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clin Infect Dis (2013) 3.05
MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 2.87
Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis (2006) 2.54
A systems approach to prion disease. Mol Syst Biol (2009) 2.49
Pyrosequencing: sequence typing at the speed of light. Mol Biotechnol (2004) 2.48
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol (2006) 2.46
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ (2006) 2.37
Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect (2002) 2.37
Comparing the MicroRNA spectrum between serum and plasma. PLoS One (2012) 2.34
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis (2005) 2.18
A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med (2015) 2.16
Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis (2008) 2.13
Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med (2012) 2.12
Genetic analysis of meningococci carried by children and young adults. J Infect Dis (2005) 2.12
Stapled hemorrhoidopexy compared with conventional hemorrhoidectomy: systematic review of randomized, controlled trials. Dis Colon Rectum (2004) 2.07
Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One (2011) 2.04
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol (2012) 2.04
Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J Bacteriol (2004) 1.93
Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine (2010) 1.91
Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol (2004) 1.83
Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol (2003) 1.78
Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence. Cell Microbiol (2008) 1.78
Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine (2011) 1.75
Incidence and prevalence of spinal cord injury in Canada: a national perspective. Neuroepidemiology (2012) 1.74
Increasing hospital admissions for pneumonia, England. Emerg Infect Dis (2008) 1.72
Evolution of competence and DNA uptake specificity in the Pasteurellaceae. BMC Evol Biol (2006) 1.71
Hybrid Vibrio vulnificus. Emerg Infect Dis (2005) 1.68
Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One (2013) 1.67
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A (2010) 1.66
Novel type IV secretion system involved in propagation of genomic islands. J Bacteriol (2006) 1.64
Expression profiling the temperature-dependent amphibian response to infection by Batrachochytrium dendrobatidis. PLoS One (2009) 1.64
Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis (2003) 1.62
Improved detection of bifidobacteria with optimised 16S rRNA-gene based pyrosequencing. PLoS One (2012) 1.62
Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study. Arch Dis Child (2007) 1.60
Clostridium difficile mixed infection and reinfection. J Clin Microbiol (2011) 1.59
A novel CRP-dependent regulon controls expression of competence genes in Haemophilus influenzae. J Mol Biol (2005) 1.57
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol (2005) 1.56
Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics (2009) 1.55
Windscreen wiper fluid without added screenwash in motor vehicles: a newly identified risk factor for Legionnaires' disease. Eur J Epidemiol (2010) 1.55
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine (2012) 1.54
Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis (2006) 1.53
Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun (2005) 1.53
Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis (2012) 1.51
Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. Clin Infect Dis (2006) 1.47
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis (2012) 1.47
Antibiotic therapy versus appendectomy for acute appendicitis: a meta-analysis. World J Surg (2010) 1.45
Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet (2012) 1.43
The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine. Infect Genet Evol (2010) 1.40
Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission. PLoS Comput Biol (2013) 1.38
Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study). BMC Med Res Methodol (2010) 1.38
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol (2010) 1.36
First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology. Appl Environ Microbiol (2006) 1.35
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J Clin Microbiol (2009) 1.32
Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J Infect Dis (2011) 1.31
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut (2012) 1.30
Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg (2010) 1.30
Comparison of automated processing of flocked swabs with manual processing of fiber swabs for detection of nasal carriage of Staphylococcus aureus. J Clin Microbiol (2011) 1.29
Role of China in the quest to define and control severe acute respiratory syndrome. Emerg Infect Dis (2003) 1.29
Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J Clin Microbiol (2004) 1.29
Self-assembled virus-like particles with magnetic cores. Nano Lett (2007) 1.28
Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine (2011) 1.28
Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates. Infect Immun (2006) 1.27
Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J Infect Dis (2004) 1.27
Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis (2012) 1.26
Risk factors for Clostridium difficile acquisition in infants: importance of study design. Clin Infect Dis (2013) 1.24
Sequence and functional analyses of Haemophilus spp. genomic islands. Genome Biol (2007) 1.23
Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. J Infect Dis (2007) 1.23
Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia. Clin Diagn Lab Immunol (2004) 1.22
Association of a bacteriophage with meningococcal disease in young adults. PLoS One (2008) 1.22